Literature DB >> 25169845

Burden of chronic obstructive pulmonary disease in the elderly population.

Seiichi Kobayashi1, Masaru Yanai2, Masakazu Hanagama3, Shinsuke Yamanda4.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease and an important health care problem in older adults. The impact of age and specific geriatric issues on COPD in elderly patients has not been well established.
METHODS: A cross-sectional study of elderly COPD patients was conducted in Japan by using a regional COPD registry database. We compared indices of disease severity (pulmonary function, exercise tolerance, quality of life, and frequency of exacerbations), presence of comorbidities, geriatric conditions (cognitive function, mental status, and activities of daily living [ADL]), and adherence to prescribed drug regimens between elderly and younger patients with COPD.
RESULTS: In total, 279 patients with stable COPD (median age, 74 years) were identified; 86% of these patients were elderly (65 years of age or older). Elderly COPD patients, especially those who were 75 years of age or older, had significantly more cases of dyspnea, lower exercise tolerance, and poorer ADL and a higher incidence of severe exacerbations than younger patients (all P<0.05). In addition, the prevalence of comorbidities, including cardiovascular disease and cancer, was significantly higher in elderly COPD patients. Elderly COPD patients had specific geriatric conditions, including cognitive impairment. Adherence to inhaled drug regimens in elderly patients was as favorable as that in younger patients.
CONCLUSIONS: Age and specific geriatric conditions have a great negative impact on COPD in elderly patients. Geriatric conditions should be addressed in the management of elderly COPD patients.
Copyright © 2014 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Drug adherence; Elderly; Geriatric condition

Mesh:

Year:  2014        PMID: 25169845     DOI: 10.1016/j.resinv.2014.04.005

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  8 in total

1.  Characteristics of Patients with Chronic Obstructive Pulmonary Disease Treated with Long-Acting Bronchodilators in a Real-World Setting in Singapore: A Single-Center Observational Study.

Authors:  Marcus Sim; Anthony Yii; Xiaomeng Xu; Priti Bahety; Chee Hong Loh; Aldo Amador Navarro Rojas; Dominique Milea; Augustine Tee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-09

2.  Early Detection of Chronic Obstructive Pulmonary Disease in Primary Care.

Authors:  Seiichi Kobayashi; Masakazu Hanagama; Masaru Yanai
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

3.  Squat-to-stand test in functional assessment of stable chronic obstructive pulmonary disease patients.

Authors:  Prahlad Rai Gupta; Asif Feroz; Sachet Dawar; Harshdeep Bhangoo; Shivani Swami; T K Khublani
Journal:  Lung India       Date:  2017 May-Jun

Review 4.  Was Sleep a Problem for the Elderly During COVID-19?

Authors:  Shahanaz Parveen; Sophia M George; Sharad Chand
Journal:  Sleep Vigil       Date:  2021-09-06

5.  Optimal Cut-Off Points of 4-meter Gait Speed to Discriminate Functional Exercise Capacity and Health Status in Older patients with Chronic Obstructive Pulmonary Disease.

Authors:  Ismail Ozsoy; Muhammed Ihsan Kodak; Nermin Zerman; Caner Kararti; Arzu Erturk
Journal:  Ann Geriatr Med Res       Date:  2022-05-18

Review 6.  Narrative review of current COPD status in Japan.

Authors:  Naoya Tanabe; Susumu Sato
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

7.  Inflammatory biomarkers in asthma-COPD overlap syndrome.

Authors:  Seiichi Kobayashi; Masakazu Hanagama; Shinsuke Yamanda; Masatsugu Ishida; Masaru Yanai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-07

8.  A multidisciplinary telehealth program in patients with combined chronic obstructive pulmonary disease and chronic heart failure: study protocol for a randomized controlled trial.

Authors:  Palmira Bernocchi; Simonetta Scalvini; Tiziana Galli; Mara Paneroni; Doriana Baratti; Ottavia Turla; Maria Teresa La Rovere; Maurizio Volterrani; Michele Vitacca
Journal:  Trials       Date:  2016-09-22       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.